PARIS: A phase I study of pembrolizumab anti-PD-1 monoclonal antibody in combination with radiotherapy (RT) in locally advanced non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Kordbacheh, T. [1 ,2 ]
Chan, C. [1 ]
Bossons, A. [2 ,3 ]
Franks, K. [4 ]
McDonald, F. [5 ]
Forster, M. [6 ]
Mendes, R. [7 ]
Quezada, S. [8 ]
Dovedi, S. [9 ]
Ralph, C. [10 ]
Popat, S. [11 ]
Harrington, K. [12 ,13 ]
Melcher, A. [14 ]
Popple, A. [9 ]
Illidge, T. [9 ]
Faivre-Finn, C. [1 ,2 ]
机构：
[1] Christie NHS Fdn Trust, Clin Oncol, Manchester, Lancs, England
[2] Univ Manchester, Manchester, Lancs, England
[3] Christie NHS Fdn Trust, Clin Trials Unit, Manchester, Lancs, England
[4] St James Univ Hosp, Leeds Canc Ctr, Clin Oncol, Leeds, W Yorkshire, England
[5] Royal Marsden NHS Fdn Trust, Clin Oncol, London, England
[6] UCL, Oncol, London, England
[7] Univ Coll London Hosp, Clin Oncol, London, England
[8] UCL Canc Inst, Immune Regulat & Tumour Immunotherapy, London, England
[9] Canc Res UK Manchester Inst, Targeted Therapy, Manchester, Lancs, England
[10] Univ Leeds, Leeds Immunotherapy Team, Leeds, W Yorkshire, England
[11] Royal Marsden Hosp, Lung Oncol Unit, London, England
[12] Royal Marsden NHS Fdn Trust, Clin Oncol, Targeted Therapy, Manchester, Lancs, England
[13] Inst Canc Res, Manchester, Lancs, England
[14] Inst Canc Res, Translat Immunol, Manchester, Lancs, England
来源：
LUNG CANCER | 2017年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
164
引用
收藏
页码：S75 / S76
页数：2
相关论文
共 50 条
  • [41] Adjuvant Chemotherapy/Radiotherapy Rates in Resectable Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
    Cheung, Francis
    Goldblatt, Joshua
    Alam, Naveed
    Wright, Gavin
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S223 - S224
  • [42] Personalized neoantigen vaccine enhances the therapeutic efficacy of bevacizumab and anti-PD-1 antibody in advanced non-small cell lung cancer
    Lin, Xiuhua
    Tang, Shichuan
    Guo, Yutong
    Tang, Ruijing
    Li, Zhenli
    Pan, Xinting
    Chen, Geng
    Qiu, Liman
    Dong, Xiuqing
    Zhang, Ling
    Liu, Xiaolong
    Cai, Zhixiong
    Xie, Baosong
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (02)
  • [43] Personalized neoantigen vaccine enhances the therapeutic efficacy of bevacizumab and anti-PD-1 antibody in advanced non-small cell lung cancer
    Xiuhua Lin
    Shichuan Tang
    Yutong Guo
    Ruijing Tang
    Zhenli Li
    Xinting Pan
    Geng Chen
    Liman Qiu
    Xiuqing Dong
    Ling Zhang
    Xiaolong Liu
    Zhixiong Cai
    Baosong Xie
    Cancer Immunology, Immunotherapy, 73
  • [44] Phase 2 Study of Nimotuzumab in Combination With Concurrent Chemoradiotherapy (CRT) in Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC)
    Tanaka, K.
    Okamoto, I.
    Yamamoto, N.
    Hattori, Y.
    Masuda, N.
    Nishio, M.
    Takeda, K.
    Seto, T.
    Nishimura, Y.
    Nakagawa, K.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S605 - S605
  • [45] Anti-PD-1 antibodies in non-small cell lung cancer (NSCLC): The real-life setting experience
    Dudnik, E.
    Moskovitz, M.
    Wollner, M.
    Zer, A.
    Bar, J.
    Agbarya, A.
    Idan, T.
    Shechtman, Y.
    Abu Amna, M.
    Peled, N.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S136 - S136
  • [46] A Pilot Study of Anti-PD-1 Antibody SHR-1210 with Hypofractionated Radiation Therapy in Patients with Oligometastatic Non-Small Cell Lung Cancer (NSCLC)
    Teng, F.
    Xing, L.
    Yu, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E535 - E535
  • [47] Combination immuno-oncology therapy with pembrolizumab, an anti-PD-1 monoclonal antibody targeting immune evasion, and standard chemotherapy for patients with the squamous and non-squamous subtypes of non-small cell lung cancer
    Katoh, Masaru
    JOURNAL OF THORACIC DISEASE, 2018, 10 (09) : 5178 - 5183
  • [48] Chemotherapy Reverses Anti-PD-1 Resistance in One Patient With Advanced Non-small Lung Cell Cancer
    Zhao Lingdi
    Ma Baozhen
    Yang Yonghao
    Li Tiepeng
    Han Lu
    Gao Quanli
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [49] Efficacy and Safety of Anti-PD-1 Inhibitors in Elderly Patients with Advanced Non-Small Cell Lung Cancer
    Tanaka, Y.
    Okano, T.
    Kudo, Y.
    Takeuchi, S.
    Makino, Y.
    Shimada, Y.
    Maehara, S.
    Hagiwara, M.
    Kakihana, M.
    Kajiwara, N.
    Ohira, T.
    Ikeda, N.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S979 - S980
  • [50] PHASE I STUDY OF CISPLATIN/DOCETAXEL CHEMOTHERAPY WITH CONCURRENT THORACIC RADIOTHERAPY IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER
    Zhang, Tina W.
    Rodrigues, George B.
    Louie, Alexander V.
    Dar, A. Rashid
    Dingle, Brian
    Sanatani, Michael
    Small, David
    Yaremko, Brian
    Younus, Jawaid
    Vincent, Mark
    RADIOTHERAPY AND ONCOLOGY, 2016, 120 : S88 - S88
12345